The purpose of this study was to examine the physiological and psychological responses to linear work rate treadmill and cycle ergometer exercise tests in men and women with chronic obstructive pulmonary disease (COPD). 12 men and 8 women with COPD completed one treadmill and one cycle cardiopulmonary exercise test (CPET) in randomized order. Before and after each CPET, the particpants completed measures of Self-Efficacy (SE), State-Anxiety, and Arousal. No significant differences were found between the physiological responses to cycle and treadmill CPET in either men or women. SE increased significantly as a result of the first test, regardless of exercise modality and sex. State anxiety was significantly reduced after the first test, whereas there was no significant change in arousal state. In conclusion there were no differences between the physiological and psychological responses to treadmill and cycle CPET in men and women with COPD.

The aim of this thesis was to modify and evaluate effects, as well as todescribe experiences of a nurse-led multidisciplinary programme of pulmonaryrehabilitation in primary health care for patients with chronicobstructive pulmonary disease (COPD) and their next of kin.Interviews were performed with 12 COPD nurses about their experiencesof patient education (I). Forty-nine patients participated in the interventiongroup and 54 in the control group in a quasi-experimentalstudy which investigated the effects of the programme on functional capacity,quality of life and exacerbation frequency during one year (II).Interviews were performed related to the experiences of 20 patients whohad participated in the six-week programme (III) and the experiences of20 next of kin to the patients that had participated (IV).The results showed that COPD nurses fluctuated between security andinsecurity in patient education and were in need of support, time, structureand collaboration to develop their patient education (I). In Study IIthere were no differences between the groups with regard to functionalcapacity and quality of life, but the number of exacerbations decreased inthe intervention group and increased in the control group (II). The patientsin study III had allowed themselves to live at their own pace followingthe programme but a constant fear was present in spite of the programme(III). Next of kin in Study IV had a life that remained overshadowedby illness but there were positive outcomes of the programme aslong as two years afterwards. The next of kin also had constant fear,however (IV).In conclusion, the six week programme brought about results in changingeveryday life. Nevertheless, all lived in the shadow of fear and uncertaintyin spite of the programme. More research is needed to address therequirements of COPD nurses, patients and next of kin.

Exhaled breath condensate (EBC) is a non-invasive method of investigating airway inflammation associated with nitric oxide (NO) and the metabolites nitrite/nitrates (NOx) in diseases such as chronic obstructive pulmonary disease (COPD), but some of the variables affecting the results are unknown. It was hypothesised that 1) EBC would be influenced by lung volumes and the type of EBC collection device; 2) fractional exhaled NO (FENO) and EBC NOx in COPD patients would be altered by smoking and glucocorticosteroids (GCS); 3) cigarette smoke could contribute to the EBC NOx concentration while it may also decrease FENO indirectly by converting airway NO to NOx. It was found that EBC volume was significantly correlated with both tidal volume and minute volume. Comparing four EBC collection devices demonstrated greater efficiency with the ECoScreen?? than siliconised glass tubes or RTube?? but it gave factitiously high NOx levels. Total EBC protein levels over a 10-minute collection were significantly higher using the ECoScreen?? than either glass or RTube?? devices. A cross-sectional study of 96 COPD patients and 80 age-matched control subjects demonstrated that FENO levels in COPD patients were significantly higher than normal subjects when comparing either the combined groups or appropriate two subgroups: ex-smokers and smokers. GCS treatment demonstrated no significant effect on either FENO levels or EBC NOx, but EBC NOx was elevated in smokers. In vitro, cigarette smoke extract (CSE) induced significantly higher NOx and asymmetric dimethylarginine (ADMA) levels in A549 cells when compared with control media. The anti-oxidant, NAC pre-treatment partially reversed the elevated NOx levels but not the ADMA levels. This thesis is the first to report FENO and EBC NOx in COPD patients in an appropriate sample size to be able to evaluate each subgroup, and the increased EBC NOx levels found in smokers in vivo was consistent with the elevated NOx level in response to CSE observed in vitro. These data indicate that smoking-related airway inflammation and activation of the NO pathway are complex with both an increase in ADMA, NO, NOx and may be regulated by oxidative stress rather than the nitric oxide synthase (NOS) pathway.

<p>BAKGRUND: KOL är en sjukdom som drabbar allt fler personer världen över och anses bli den tredje vanligaste dödsorsaken i världen år 2020. Det finns inget botemedel mot KOL men genom omfattande omvårdnad kan patienten och anhöriga uppleva välbefinnande trots sjukdomen. Andningssvårigheterna påverkar patientens vardagliga liv och livskvalitet negativt både psykiskt och fysiskt. SYFTE: Syftet med denna studie var att belysa hur sjuksköterskor kan underlätta vid andningssvårigheter för patienter med sjukdomen KOL med utgångspunkt från både patienters önskemål och sjuksköterskors erfarenheter. METOD: Studien var en litteraturöversikt baserad på redan vetenskapligt framforskat datamaterial. Datamaterialet inom ämnet som format resultatet begränsades till nio vetenskapliga artiklar, både av kvalitativ- och kvantitativ karaktär. RESULTAT: Det framstår tre teman; kontinuerligt utbyte av kunskaper, spara på patientens krafter samt ge stöd och trygghet. Kontinuerligt utbyte av kunskaper innebär det kunskapsutbyte som sker mellan patienter och sjuksköterskor i omvårdnaden. Det andra temat beskriver hur patienters andning påverkas genom planering av vardagen och det sista temat visar på de psykiska aspekterna. DISKUSSION: Denna studie visar på vikten av en god relation mellan sjuksköterskor och patienter för att omvårdnaden ska bli av bästa kvalitet. Med en god relation skapas trygghet och tillförlitlighet vilket är det viktigaste för patienter med KOL.</p> / <p>BACKGROUND: COPD is a disease that increasingly affects more patients around the world; by 2020 is it is projected to be the third most common cause of death. There is no cure against COPD. Moreover, difficulty breathing affects the patient’s quality of life physically and mentally. However, with extensive care patients and their relatives can experience wellbeing in spite of the illness. PURPOSE: The aim of this study is to illustrate how nurses can ease the suffering of patients with COPD with a starting point from the patient’s wishes and the nurse’s experience. METHOD: The study was a literature review based on existing researched data material based on nine scientific articles of qualitative and quantitative nature.</p><p>RESULT: Three themes emerged: the continuously exchange of knowledge; saving the patients strength; and give security and support. The continuously exchange of knowledge refers to knowledge exchange between nurse and patient during the caring process. The second theme describes how the patient’s breathing is affected by the planning of everyday life. The last theme illustrates the mental aspects. CONCLUSION: This study shows a good relationship between patient and nurse is important to create security and support which are the most important things for patients suffering from COPD.</p>

Submitted by JOSÉ WILLIAM ZUCCHI null (jwzucchi@hotmail.com) on 2018-04-02T23:13:39Z No. of bitstreams: 1 Dissertação Mestrado José W. Zucchi.pdf: 2342865 bytes, checksum: 860bbd3c7b2672c61b7ca6b121b0e8f9 (MD5) / Approved for entry into archive by Luciana Pizzani null (luciana@btu.unesp.br) on 2018-04-03T12:55:11Z (GMT) No. of bitstreams: 1 zucchi_jw_me_bot.pdf: 2342865 bytes, checksum: 860bbd3c7b2672c61b7ca6b121b0e8f9 (MD5) / Made available in DSpace on 2018-04-03T12:55:11Z (GMT). No. of bitstreams: 1 zucchi_jw_me_bot.pdf: 2342865 bytes, checksum: 860bbd3c7b2672c61b7ca6b121b0e8f9 (MD5) Previous issue date: 2018-02-28 / Introdução: Os pacientes com doença pulmonar obstrutiva crônica (DPOC) exibem características clínicas heterogêneas que estão associados a diferentes respostas a tratamentos e prognósticos. A complexidade da doença faz com que sejam buscadas ferramentas alternativas como o agrupamento de cluster para a identificação de características específicas e que possam tratadas diferentemente dentro da mesma doença. Entretanto, ainda são escassos dados da América Latina em relação aos possíveis clusters da DPOC. Objetivo: Avaliar os possíveis clusters na DPOC em dois centros de estudo no Brasil. Métodos: Os pacientes foram submetidos à avaliação composta por doenças associadas, Índice de Charlson, composição corporal, fármacos atuais, história de tabagismo (anos/maço), monóxido de carbono exalado, histórico de exacerbações/ hospitalizações no último ano, espirometria, teste de caminhada de seis minutos, questionários de qualidade de vida, dispneia e escala hospitalar de ansiedade e depressão. Também foram coletadas amostras de sangue para dosagens de proteína C reativa (PCR), gases sanguíneos, análise laboratorial e hemograma. Resultados: Foram avaliados 334 pacientes portadores de sintomas respiratórios e fator de risco para DPOC. Desse total, 13 pacientes foram excluídos do estudo por não terminarem o protocolo, 20 pacientes sem diagnóstico de DPOC e 10 por não terem sido classificados em nenhum cluster. Assim, foram incluídos 291 pacientes [53,6% homem, 67,5 ± 9,6 anos e volume expiratório forçado no primeiro segundo (VEF1) = 45,5 ± 17,9]. Para a construção dos clusters foram selecionadas 13 variáveis continuas e realizado análise com o método de Ward e método K means que determinaram quatro clusters. O primeiro cluster foi caracterizado por menor gravidade sintomática e funcional da doença, o segundo grupo por maior valor de eosinófilos periféricos, o terceiro grupo por serem mais inflamados sistemicamente e o quarto grupo por serem com maior gravidade obstrutiva e pior troca gasosa. O cluster 2 apresentou média de 959± 3 eosinófilos periféricos, cluster 3 apresentou maior prevalência de depleção nutricional (46,1%) e o cluster 4 apresentou maior índice BODE. Em relação as comorbidades associadas identificamos que apenas a síndrome de apneia obstrutiva do sono e o tromboembolismo pulmonar foram mais prevalentes no cluster 4. Conclusão: As manifestações clínicas e comorbidades associadas da DPOC identificadas nos quatros diferentes clusters deste estudo mostram as características heterogêneas da doença e isso pode estar relacionado à desfechos prognósticos diferentes em cada cluster podem diferenciar o tratamento em cada agrupamento com maior efetividade. / Introduction: Patients with chronic obstructive pulmonary disease (COPD) exhibit heterogeneous clinical features that are associated with different responses to treatments and prognoses. The complexity of the disease causes alternative tools such as clustering to identify specific characteristics and that can be treated differently within the same disease. However, there are still little data from Latin America regarding possible clusters in COPD. Objective: To evaluate possible clusters in COPD in two Brazilian centers. Methods: We assesses the comorbidities, Charlson's index, body composition, pharmacological treatment, smoking history (pack-years), exhaled carbon monoxide, exacerbations/hospitalizations rate in the last year, spirometry, six-minute walk test, quality of life questionnaires, dyspnea and hospital anxiety and depression scale. We also collected blood gases, laboratory and blood counts. Results: A total of 334 patients with respiratory symptoms and a risk factor for COPD were evaluated. From the total, 13 patients were excluded from the study because they didn’t complete the protocol, 20 patients without a diagnosis of COPD and 10 because they were not classified in any cluster. Thus, 291 patients were included [53.6% male, 67.5 ± 9.6 years and forced expiratory volume in the first second (FEV1) = 45.5 ± 17.9]. For the construction of the clusters, 13 continuous variables were selected and an analysis was performed with the Ward method and K method, which determined four clusters. The first cluster was characterized by lower symptomatic and mild COPD. The second cluster was characterized by higher value of peripheral eosinophils, the third cluster with systemic inflammation and the fourth cluster had severe COPD and worst gas exchange. Cluster 2 presented a mean of 959 ± 3 peripheral eosinophils, cluster 3 presented a higher prevalence of nutritional depletion (46.1%) and cluster 4 presented higher BODE index. In relation to the associated comorbidities, we identified that only obstructive sleep apnea syndrome and pulmonary thromboembolism were more prevalent in cluster 4. Conclusion: The clinical manifestations and associated comorbidities of COPD identified in the four different clusters of this study show the heterogeneous characteristics of the disease and this may be related to different outcomes and treatment.

Submitted by BRUNA EVELYN BUENO DE MORAIS null (bruninha_fisio_btu@hotmail.com.br) on 2018-04-04T23:49:21Z No. of bitstreams: 1 Dissertacao Mestrado.pdf: 2901617 bytes, checksum: 7115c5d432efdb7d486f289b990a699f (MD5) / Approved for entry into archive by Luciana Pizzani null (luciana@btu.unesp.br) on 2018-04-06T14:24:21Z (GMT) No. of bitstreams: 1 morais_beb_me_bot.pdf: 2901617 bytes, checksum: 7115c5d432efdb7d486f289b990a699f (MD5) / Made available in DSpace on 2018-04-06T14:24:21Z (GMT). No. of bitstreams: 1 morais_beb_me_bot.pdf: 2901617 bytes, checksum: 7115c5d432efdb7d486f289b990a699f (MD5) Previous issue date: 2018-02-28 / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / Introdução: A DPOC é uma doença progressiva e que requer tratamento farmacológico para o controle dos sintomas respiratórios. Entretanto, são escassos dados brasileiros que avaliaram o uso de fármacos conforme a gravidade da doença e que verificaram sua adesão ao tratamento da DPOC. Objetivo: Avaliar a adequação, aderência e técnica do tratamento farmacológico pulmonar em relação à gravidade nos pacientes com DPOC. Métodos: Foram avaliados 181 pacientes com DPOC leve a muito grave (47,5 % sexo masculino) com idade: 67,7 ± 9,8 anos e volume expiratório forçado no primeiro segundo (VEF1): 44,6 ± 17,1%. Todos pacientes foram avaliados quanto à adequação farmacológica (GOLD 2017), magnitude da dispneia (Medical ResearchCouncil Modificado – MMRC), Questionário COPD Assessment Test (CAT), frequência de exacerbações no último ano, aderência referida aos fármacos inalatórios e a verificação da técnica dos dispositivos inalatórios. Resultados: Do total de pacientes avaliados, ao separar pela gravidade GOLD, obtivemos GOLD I = 9, GOLD II = 48, GOLD III = 62 e GOLD IV = 62 e ao separar pelos grupos sintomáticos, obtivemos: A = 40, B = 112, C = 5 e D= 24. Em relação à adequação ao tratamento farmacológico pulmonar, 40% do grupo A e 72,5% do grupo B estavam utilizando corticoide inalatório sem história de exacerbações no último ano. Quanto à aderência referida ao tratamento e à técnica do dispositivo inalatório, observamos que a maioria estava aderente (78%) e realizavam a técnica de maneira adequada (64 %). Conclusão: Há utilização de excesso de corticoide inalatório nos pacientes com doença mais leve. Entretanto, a maioria dos pacientes aderem ao tratamento e fazem o uso de dispositivo inalatório corretamente. / Background: COPD is a progressive disease and requires pharmacological treatment to control respiratory symptoms. However, there are few Brazilian data that evaluated the use of pharmacological treatment according to the disease severity or verified their adherence to COPD treatment. Objective: To evaluate the adequacy, adherence and technique of pulmonary pharmacological treatment in relation to severity in COPD patients. Methods: We evaluated 181 patients with mild to very severe COPD (47.5% male) with age: 67.7 ± 9.8 years old and forced expiratory volume in the first second (FEV1): 44.6 ± 17.1%. All patients were evaluated by pharmacological adequacy (GOLD 2017), dyspnea’s magnitude (Medical Research Council Modified - MMRC), COPD Assessment Test (CAT), frequency of exacerbations in the last year, adherence to inhaled pharmacological treatment and technique’s verification devices. Results: We obtained GOLD I = 9, GOLD II = 48, GOLD III = 62 and GOLD IV = 62, and when separated by symptomatic groups, we obtained: A = 40, B = 112, C = 5 and D = 24. Regarding the suitability for pulmonary pharmacological treatment, 40% of group A and 72.5% of group B were using inhaled corticosteroids with no history of exacerbations in the last year. Regarding the adherence to the treatment and technique of the inhaler device, we observed that the majority were adherent (78%) and performed the technique adequately (64%). Conclusion: There is an excess of inhaled corticosteroids in patients with milder disease. However, most patients adhere to treatment and use inhaled device correctly. Key-words: COPD, adherence, adequacy, technique, inhalation device / 40101002

Att utveckla och bibehålla situation awareness (SA) är en av de mest kritiska utmaningar i en stab i dagens konflikter. Det får avgörande betydelse för utgången av en konflikt. Om SA hanteras eller förstås felaktigt kan det leda till ökat mänskligt lidande i konfliktområden och förluster av människoliv. Det ökande internationella samarbetet gör att planeringsofficeren förutsätts kunna hantera flera olika processer. Syftet med uppsatsen var att jämföra och belysa skillnader hur SA skapas inom olika planeringsprocesser, samt vad försvårar utväxlingen av SA mellan processerna. Detta återspeglas i form av likheter och skillnader mellan planeringsmodellerna SPL, MCPP och COPD. Resultatet visar att det fanns stor likhet mellan processerna men det fanns också avgörande skillnader. I SA nivå 1 fanns en diskrepans mellan begreppen Centre of Gravity, caveats och gender. I SA nivå 2 skiljer bearbetningsprocesserna mellan planeringsmodellerna. I SA nivå 3 fanns den största och mest avgörande skillnaden där det kan konstateras att planeringsprocesserna inte utgår från samma byggstenar när det gäller att bygga planen. Medvetenhet och insikt för de olika planeringsprocessernas särart minskar risken för missförstånd.

Orientador: Suzana Erico Tanni Minamoto / Resumo: Introdução: Os pacientes com doença pulmonar obstrutiva crônica (DPOC) exibem características clínicas heterogêneas que estão associados a diferentes respostas a tratamentos e prognósticos. A complexidade da doença faz com que sejam buscadas ferramentas alternativas como o agrupamento de cluster para a identificação de características específicas e que possam tratadas diferentemente dentro da mesma doença. Entretanto, ainda são escassos dados da América Latina em relação aos possíveis clusters da DPOC. Objetivo: Avaliar os possíveis clusters na DPOC em dois centros de estudo no Brasil. Métodos: Os pacientes foram submetidos à avaliação composta por doenças associadas, Índice de Charlson, composição corporal, fármacos atuais, história de tabagismo (anos/maço), monóxido de carbono exalado, histórico de exacerbações/ hospitalizações no último ano, espirometria, teste de caminhada de seis minutos, questionários de qualidade de vida, dispneia e escala hospitalar de ansiedade e depressão. Também foram coletadas amostras de sangue para dosagens de proteína C reativa (PCR), gases sanguíneos, análise laboratorial e hemograma. Resultados: Foram avaliados 334 pacientes portadores de sintomas respiratórios e fator de risco para DPOC. Desse total, 13 pacientes foram excluídos do estudo por não terminarem o protocolo, 20 pacientes sem diagnóstico de DPOC e 10 por não terem sido classificados em nenhum cluster. Assim, foram incluídos 291 pacientes [53,6% homem, 67,5 ± 9,6 anos e volume expi... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Introduction: Patients with chronic obstructive pulmonary disease (COPD) exhibit heterogeneous clinical features that are associated with different responses to treatments and prognoses. The complexity of the disease causes alternative tools such as clustering to identify specific characteristics and that can be treated differently within the same disease. However, there are still little data from Latin America regarding possible clusters in COPD. Objective: To evaluate possible clusters in COPD in two Brazilian centers. Methods: We assesses the comorbidities, Charlson's index, body composition, pharmacological treatment, smoking history (pack-years), exhaled carbon monoxide, exacerbations/hospitalizations rate in the last year, spirometry, six-minute walk test, quality of life questionnaires, dyspnea and hospital anxiety and depression scale. We also collected blood gases, laboratory and blood counts. Results: A total of 334 patients with respiratory symptoms and a risk factor for COPD were evaluated. From the total, 13 patients were excluded from the study because they didn’t complete the protocol, 20 patients without a diagnosis of COPD and 10 because they were not classified in any cluster. Thus, 291 patients were included [53.6% male, 67.5 ± 9.6 years and forced expiratory volume in the first second (FEV1) = 45.5 ± 17.9]. For the construction of the clusters, 13 continuous variables were selected and an analysis was performed with the Ward method and K method, which dete... (Complete abstract click electronic access below) / Mestre

Orientador: Suzana Erico Tanni Minamoto / Resumo: Introdução: A DPOC é uma doença progressiva e que requer tratamento farmacológico para o controle dos sintomas respiratórios. Entretanto, são escassos dados brasileiros que avaliaram o uso de fármacos conforme a gravidade da doença e que verificaram sua adesão ao tratamento da DPOC. Objetivo: Avaliar a adequação, aderência e técnica do tratamento farmacológico pulmonar em relação à gravidade nos pacientes com DPOC. Métodos: Foram avaliados 181 pacientes com DPOC leve a muito grave (47,5 % sexo masculino) com idade: 67,7 ± 9,8 anos e volume expiratório forçado no primeiro segundo (VEF1): 44,6 ± 17,1%. Todos pacientes foram avaliados quanto à adequação farmacológica (GOLD 2017), magnitude da dispneia (Medical ResearchCouncil Modificado – MMRC), Questionário COPD Assessment Test (CAT), frequência de exacerbações no último ano, aderência referida aos fármacos inalatórios e a verificação da técnica dos dispositivos inalatórios. Resultados: Do total de pacientes avaliados, ao separar pela gravidade GOLD, obtivemos GOLD I = 9, GOLD II = 48, GOLD III = 62 e GOLD IV = 62 e ao separar pelos grupos sintomáticos, obtivemos: A = 40, B = 112, C = 5 e D= 24. Em relação à adequação ao tratamento farmacológico pulmonar, 40% do grupo A e 72,5% do grupo B estavam utilizando corticoide inalatório sem história de exacerbações no último ano. Quanto à aderência referida ao tratamento e à técnica do dispositivo inalatório, observamos que a maioria estava aderente (78%) e realizavam a técnica de mane... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Background: COPD is a progressive disease and requires pharmacological treatment to control respiratory symptoms. However, there are few Brazilian data that evaluated the use of pharmacological treatment according to the disease severity or verified their adherence to COPD treatment. Objective: To evaluate the adequacy, adherence and technique of pulmonary pharmacological treatment in relation to severity in COPD patients. Methods: We evaluated 181 patients with mild to very severe COPD (47.5% male) with age: 67.7 ± 9.8 years old and forced expiratory volume in the first second (FEV1): 44.6 ± 17.1%. All patients were evaluated by pharmacological adequacy (GOLD 2017), dyspnea’s magnitude (Medical Research Council Modified - MMRC), COPD Assessment Test (CAT), frequency of exacerbations in the last year, adherence to inhaled pharmacological treatment and technique’s verification devices. Results: We obtained GOLD I = 9, GOLD II = 48, GOLD III = 62 and GOLD IV = 62, and when separated by symptomatic groups, we obtained: A = 40, B = 112, C = 5 and D = 24. Regarding the suitability for pulmonary pharmacological treatment, 40% of group A and 72.5% of group B were using inhaled corticosteroids with no history of exacerbations in the last year. Regarding the adherence to the treatment and technique of the inhaler device, we observed that the majority were adherent (78%) and performed the technique adequately (64%). Conclusion: There is an excess of inhaled corticosteroids in patients ... (Complete abstract click electronic access below) / Mestre

Orientador: Suzana Erico Tanni Minamoto / Resumo: Introdução: Estudos recentes mostram que o tecido adiposo também contribui para a inflamação sistêmica em pacientes com DPOC. Entretanto, não há dados na literatura que avaliem a variação das adipocinas e suas associações com marcadores inflamatórios, exacerbações e mortalidade em um ano nos pacientes com DPOC. Objetivo: Avaliar as variações das adipocinas, citocinas inflamatórias e composição corporal em pacientes com DPOC no período de um ano. Pacientes e Métodos: Foram avaliados 57 pacientes com DPOC leve a muito grave, destes 6 pacientes morreram, 6 não foram contatados após a avaliação e 5 não quiseram participar da segunda fase estudo, logo realizamos análise de dois momentos dos 40 pacientes que completaram um ano de acompanhamento. No momento basal e após 1 ano foram realizados espirometria pré e pós-broncodilatador, gasometria arterial, exames laboratoriais, oximetria de pulso, dosagem plasmática sérica de interleucina (IL)-6, fator de necrose tumoral alfa (TNF-α), adiponectina e leptina e avaliação sérica laboratorial. Também foi realizado avaliação da composição do corpo, força muscular do quadríceps (FMQ) (MicroFet 2), sensação de dispneia, por meio do Índice de Dispneia Basal (BDI), Escala de Borg e Medical Research Council Modificado (mMRC), avaliação do estado geral de saúde, por meio do questionário de Qualidade de Vida na Doença Respiratória do Hospital Saint George (SGRQ) e Escala Hospitalar de Ansiedade e Depressão (HAD), calculado índice de BODE e Teste de... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Introduction: Recent studies show that adipose tissue also contributes to systemic inflammation in chronic obstructive pulmonary disease (COPD). However, there are no data in the literature evaluating the evolution of level of adipokines and their associations with systemic inflammation, exacerbations and mortality in COPD patients. Objective: Evaluate the variations of adipokines and their association with systemic inflammation and and body composition in patients with COPD during one year. Patients and Methods: Fifty-seven patients with mild to very severe COPD were evaluated. During the follow up, six patients died, six lost the follow up and five refused to participate in the second assessment. At baseline and after one year we performed post-bronchodilator spirometry, arterial blood gas analysis, laboratory tests, pulse oximetry, serum plasma levels of interleukin (IL)-6, tumor necrosis factor alpha (TNF-α), adiponectin and leptin. We also assessed body composition, peripheral muscle strength (quadriceps), Basal Dyspnea Index (BDI), Borg Scale, and Modified Medical Research Council (mMRC), general health status was evaluated by Saint George Respiratory Questionnaire (SGRQ), Hospital Anxiety and Depression Scale (HAD), BODE index and 6-minute walk test. Results: From the total of 40 patients, we analyzed the variation during one year and we observed a positive association between leptin and BMI (R:0.43; p=0.006), QMS L (R:0.42; p=0.008) and BODE index (R:0.39; p=0.024) an... (Complete abstract click electronic access below) / Doutor